|
RNMT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.494020E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.508200E-02 |
| Normal-vs-Stage2 |
1.543590E-01 |
| Normal-vs-Stage3 |
5.681600E-01 |
| Normal-vs-Stage4 |
6.183200E-01 |
| Stage1-vs-Stage2 |
8.271400E-01 |
| Stage1-vs-Stage3 |
5.394400E-01 |
| Stage1-vs-Stage4 |
8.320400E-01 |
| Stage2-vs-Stage3 |
7.016400E-01 |
| Stage2-vs-Stage4 |
9.319400E-01 |
| Stage3-vs-Stage4 |
8.769000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.050200E-01 |
| Normal-vs-AfricanAmerican |
7.928500E-02 |
| Normal-vs-Asian |
2.443700E-02 |
| Caucasian-vs-AfricanAmerican |
4.512400E-01 |
| Caucasian-vs-Asian |
4.158600E-01 |
| AfricanAmerican-vs-Asian |
4.709800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.814170E-02 |
| Normal-vs-Female |
2.595400E-01 |
| Male-vs-Female |
2.624200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.868000E-01 |
| Normal-vs-Extreme_Weight |
6.980600E-04 |
| Normal-vs-Obese |
7.209800E-01 |
| Normal-vs-Extreme_Obese |
2.782800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.860300E-02 |
| Normal_Weight-vs-Obese |
7.568400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.721600E-01 |
| Extreme_Weight-vs-Obese |
1.994340E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.641200E-01 |
| Obese-vs-Extreme_Obese |
4.640800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.631400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.692200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.152200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.359380E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.139200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.156630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.790120E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.229900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.710300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.957400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.274390E-02 |
| Normal-VS-Type2 PRCC |
2.688200E-01 |
| Normal-VS-KIRP CIMP |
3.168800E-01 |
| Normal-VS-Unclassified PRCC |
8.412400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.708200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.416300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.669780E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.607000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.670200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.553800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.079700E-02 |
| Normal-vs-N1 |
4.167600E-01 |
| Normal-vs-N2 |
8.923800E-01 |
| N0-vs-N1 |
4.313900E-02 |
| N0-vs-N2 |
3.380600E-01 |
| N1-vs-N2 |
7.814600E-01 |
|
|
